Melissa A. Yeager, J.D.

Ms. Melissa Yeager has served in executive management for over 25 years in biopharmaceutical and medical device companies with responsibility for international regulatory affairs and operation activities. Ms. Yeager has held senior positions in global corporations such as Gilead Sciences and Becton Dickinson and start-up entities including Breath Therapeutics, Corus Pharma and PathoGenesis. In 2010, she co-founded Cardeas Pharma, a venture backed effort to develop combination therapies for respiratory infectious disease. Prior to joining Accelerator, Ms. Yeager was at Alder Biosciences with leadership responsibility for regulatory approvals of neurological products. Her areas of expertise have included early development efforts, life cycle management, and alternative dose delivery systems for biologic, drug, medical device and combination products.

Ms. Yeager received her J.D. from Santa Clara University and B.A. in Human Biology from Stanford University.  She currently heads the Regulatory Consulting Group, Seattle that focuses on complex regulatory and novel development strategies for biotechnology products. She is a member of multiple nonprofit and government entity boards.